Study Committee Examines AI in Health Care

Artificial intelligence is increasingly being used in health care, from assisting with medical documentation and clinical care to supporting insurance and administrative functions. The Wisconsin Legislative Council’s Study Committee on the Use of Artificial Intelligence in Health Care is examining how the technology is being used and whether additional state standards may be needed.

The committee is chaired by Sen. Rachael Cabral-Guevara (R-Fox Crossing), with Rep. Adam Neylon (R-Pewaukee) serving as vice chair. It also includes Sen. Sarah Keyeski (D-Lodi) and Rep. Mike Bare (D-Verona), along with 12 public members representing a range of health care, technology and other fields.

The committee’s charge includes examining AI in the patient-provider relationship, interactions between insurers or medical assistance programs and patients, and the use of AI by insurers and providers in health care coverage decisions. Following its review, the committee is directed to consider recommending legislation addressing standards for the use of AI in health care services and insurance.

Several issues have emerged during the committee’s meetings, including patient privacy, human oversight, transparency, accountability and bias. Members have discussed the growing use of AI tools to assist with clinical documentation and other health care functions, as well as questions about protecting patient information and ensuring that health care professionals remain accountable for decisions involving AI.

The committee also has considered the differences between AI tools used within regulated health care settings and consumer AI applications. Members have raised questions about how consumers should be informed about the privacy protections, limitations and potential risks associated with AI tools they may use outside of a traditional health care setting.

Another major area of discussion is the use of AI by insurers. Committee members have examined automated decision-making in areas such as prior authorization and coverage determinations, with discussions focusing on human accountability, transparency and appropriate oversight. Members have also raised questions about how to address potential bias and how existing state and federal requirements should interact with any new Wisconsin standards.

At meetings on September 9 and 10, the committee heard from more than two dozen health care organizations and other stakeholders representing providers, payers, regulators and technology interests. Discussions included potential approaches to regulation, including whether Wisconsin should consider a regulatory “sandbox” that would allow new AI applications to be tested under controlled conditions.

The committee is now moving from information-gathering toward identifying potential policy recommendations. The group is expected to continue discussing specific policy areas and potential legislation through the remainder of the year, with recommendations to the Legislature anticipated by year-end.